Chief Executive Officer

Michael Egan has had more than 25 years in the pharmaceutical, natural medicine and biotechnology sectors prior to joining Ranvet in July, 2010.

Michael has extensive sales, marketing and general management experience gained in Australia, Asia, Europe, the Middle East and Africa, and with both large multinational (including Roche, Warner Lambert, Novartis) and small specialised companies (including Scigen, Ranbaxy, Chondrogenesis, Bresagen). As well as senior management roles across geographies and health industry sectors, he has also worked with emerging companies in the biotechnology sector to prepare product development and commercialisation direction. This commercial and technical knowledge and experience will bring a new business focus to Ranvet and provide strong direction for growth through consolidation and innovation.

Michael is a graduate of the University of Sydney (MSc, pharmacology) and is a Member of The Australian Institute of Company Directors.

Finance and Administration Manager

Trevor Daley has been Ranvet’s Finance and Administration Manager since 1999.

Trevor is a Chartered Accountant with varied experience. After qualifying he held various senior roles within the finance industry and, immediately prior to joining Ranvet, had operated a successful small service business for over ten years.

He understands the importance of our business partner relationships with customers and suppliers and is happy to become involved resolving administration or procedural matters.